Company Registration No. 12127911 (England and Wales)
"AVICENNA-MED" LTD
Unaudited accounts
for the year ended 31 July 2022
"AVICENNA-MED" LTD
Unaudited accounts
Contents
"AVICENNA-MED" LTD
Company Information
for the year ended 31 July 2022
Director
Veselin Stefanov Dimitrov
Company Number
12127911 (England and Wales)
Registered Office
3 REDSAND CLOSE
WILLENHALL
WV12 4EZ
ENGLAND
Accountants
DoKument Ltd
Office 1
37 Marsh Parade
Newcastle-under-Lyme
Staffordshire
ST5 1BT
"AVICENNA-MED" LTD
Statement of financial position
as at
31 July 2022
Cash at bank and in hand
994
1,496
Creditors: amounts falling due within one year
5,910
(10,376)
Net current assets/(liabilities)
6,904
(8,880)
Total assets less current liabilities
7,432
(8,087)
Creditors: amounts falling due after more than one year
(5,126)
-
Net assets/(liabilities)
2,306
(8,087)
Called up share capital
2
2
Profit and loss account
2,304
(8,089)
Shareholders' funds
2,306
(8,087)
For the year ending 31 July 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 18 November 2022 and were signed on its behalf by
Veselin Stefanov Dimitrov
Director
Company Registration No. 12127911
"AVICENNA-MED" LTD
Notes to the Accounts
for the year ended 31 July 2022
"AVICENNA-MED" LTD is a private company, limited by shares, registered in England and Wales, registration number 12127911. The registered office is 3 REDSAND CLOSE, WILLENHALL, WV12 4EZ, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives: 25% Straight Line
Computer equipment
25% Straight Line
4
Tangible fixed assets
Computer equipment
Cost or valuation
At cost
5
Creditors: amounts falling due within one year
2022
2021
Taxes and social security
303
-
Loans from directors
(6,213)
10,376
"AVICENNA-MED" LTD
Notes to the Accounts
for the year ended 31 July 2022
6
Creditors: amounts falling due after more than one year
2022
2021
Taxes and social security
5,126
-
As at 31 July 2022 the director of the company owed £6,212 to the company (31 July 2021; £0,00) in respect of interest free loan, which is repayable on demand.
8
Average number of employees
During the year the average number of employees was 2 (2021: 2).